Wu Zhiying

[Expert Profile] Wu Zhiying, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in neurogenetics in China, working in the Department of Neurology, Huashan Hospital, Fudan University. She has long been dedicated to the clinical and genetic research of Wilson's disease, hereditary ataxia, and other hereditary neurological diseases, and is a leading figure in neurogenetics in China.

[Education & Career] Professor Wu Zhiying graduated from a renowned medical university, completed systematic training at top domestic medical institutions including Zhejiang University and Fudan University, and further studied at famous international neurogenetics research centers, mastering cutting-edge molecular genetics and neurology techniques. She is currently a Professor in the Department of Neurology, Huashan Hospital, Fudan University, holding academic positions such as deputy leader of the Neurogenetics Group of the Neurology Branch of the Chinese Medical Association. She has presided over multiple national-level projects including key grants from the National Natural Science Foundation of China, and is a representative scholar in neurogenetics research in China.

[Areas of Expertise] Professor Wu specializes in the standardized diagnosis and treatment of Wilson's disease (hepatolenticular degeneration), genetic subtyping and precise management of hereditary ataxia, and the diagnosis, treatment, and genetic counseling of various hereditary neurological diseases. She has extensive experience in copper metabolism assessment, copper-chelation therapy, and liver transplant evaluation for Wilson's disease. She excels at identifying disease causes in hereditary disease patients through the combination of genetic testing and clinical phenotype, and provides scientific reproductive guidance and follow-up plans for different families, helping numerous families affected by genetic diseases scientifically address their conditions.

[Academic Achievements & Industry Contributions] Professor Wu has led the establishment of one of the largest neurogenetics clinical cohorts and genetic databases in China, systematically conducting research on the gene mutation spectrum and clinical features of Wilson's disease, spinocerebellar ataxia, and hereditary spastic paraplegia, and has discovered and reported multiple novel pathogenic gene variants, with findings published in authoritative domestic and international genetics and neurology journals. She has participated in the development of Chinese neurogenetics diagnosis and treatment guidelines and expert consensus statements, actively promoted the standardized clinical application of molecular diagnostic techniques for genetic diseases, and led multi-center clinical trials, enabling numerous patients with rare hereditary diseases to receive clear diagnoses and standardized treatment, significantly advancing the field of neurogenetics in China.

[Clinical Practice & Outstanding Contributions] Professor Wu has long held specialist neurogenetics clinics, cumulatively treating tens of thousands of patients with various hereditary and difficult neurological diseases, many of whom travel from across the country to seek her care. She is exceptionally meticulous with every hereditary disease patient, insisting on tracing family lineages and drawing genetic pedigrees, and has identified the genetic roots of numerous "familial mysterious diseases." She is enthusiastic about public welfare, repeatedly organizing free clinics and science popularization for genetic diseases, helping rare disease families correctly understand their conditions and make informed reproductive decisions. She is deeply respected and loved by patients and their families, and is a recognized authoritative expert in neurogenetics both domestically and internationally.

[Honors & Reputation] Professor Wu Zhiying serves as leader of the Neurogenetics Group of the Neurology Branch of the Chinese Medical Association, among other academic positions. She has presided over multiple national-level projects including key grants from the National Natural Science Foundation of China and the National Key R&D Program, and is an authoritative expert in the field of neurogenetics in China. She has led the establishment of a nationwide neurogenetics clinical and genetic diagnosis collaboration network, systematically conducting genetic diagnosis, family studies, and standardized treatment for Wilson's disease, hereditary ataxia, and other conditions, bringing Chinese neurogenetics diagnosis and treatment standards to internationally advanced levels. Her research findings have been published in international authoritative journals and received multiple science and technology awards. She has trained a large number of neurogenetics specialists, helping numerous patients with rare hereditary diseases identify their disease causes and receive precise management, and is deeply respected by patients and peers alike.